Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary CNS Lymphoma
NCT00000801Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, doxorubicin, vincristine, dexamethasone, filgrastim in primary central nervous system lymphoma (PCNSL), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
cyclophosphamidedoxorubicinvincristinedexamethasonefilgrastim
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00000801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000801.